2m 2m 2m 2m 2m 2m 2m
FOGHORN THERAP (FHTX)
NASDAQ
$2.06-$0.86 (-29.59%)
Price as of Oct 02, 2026 5:33 PM EDT- $173.4MMarket Cap
- -35.68%1-Year Change
- BiotechnologyIndustry
FOGHORN THERAP (FHTX)
$2.06-$0.86 (-29.59%)
FHTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.92 | ||
Change | -$0.65 (-18.21%) | ||
Open | $2.08 | ||
High | $3.21 | ||
Low | $1.79 | ||
Previous Close | $3.57 | ||
Volume | 13,378,302 | ||
30-Day Average Volume | 1,037,633 | ||
1-Week Change | -18.89% | ||
1-Month Change | -48.68% | ||
1-Year Change | -35.68% | ||
3-Year Change | -41.60% | ||
5-Year Change | -79.55% | ||
Fundamentals | |||
Shares Outstanding | 59.4M | ||
Total Assets | $203.4M | ||
Market Cap | $173.4M | ||
Enterprise Value | $105.3M | ||
Period: QTR TTM FY | |||
Revenue | $16.1M | ||
Net Income | -$7.2M | ||
Free Cash Flow | -$17.9M | ||
EBIT | -$7.2M | ||
EBITDA | -$7.0M | ||
Net Working Capital | $119.5M | ||
EPS | -$0.10 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | 7 | ||
P/B | -2 | ||
P/E | -29 | ||
PEG | -0 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue